IndiaTickerLatest filing: Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Change in Management
ObservedCompany dossier
Jagsonpal Pharmaceuticals
NSE:JAGSNPHARM · ISIN INE048B01035
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Jagsonpal Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹74 Cr · PAT ₹32 Cr.
Exchange XBRLLatest ownership: promoter group 69.05% and public 30.95% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Jagsonpal Pharmaceuticals Limited: Ratings withdrawn
Agency sourceMaterial events
Open timeline →What changed recently
Observed
Source filing Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Change in Management
BSE · exchange filing
Observed
Source filing Change in Management - Jagsonpal Pharmaceuticals Limited
NSE · exchange filing
Observed
Source filing Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
BSE · exchange filing
Observed
Source filing General Updates - Jagsonpal Pharmaceuticals Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹74 Cr
- Profit after tax
- ₹32 Cr
- EPS
- ₹4.74
Observed NSE structured filing · Non-Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 69.05%
- Public
- 30.95%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL